Hannah Christina Puhr: Honored to Receive the Innovation Award from the Austrian Society of Hematology and Medical Oncology
Hannah Christina Puhr, Physician-scientist and Specialist for Medical Oncology at the Medical University of Vienna, shared Austrian Society for Hematology and Medical Oncology (OeGHO)’s on LinkedIn:
“I am honored to receive the Innovation Award from the Austrian Society of Hematology and Medical Oncology (OeGHO) for a project developed during my fellowship at EORTC – European Organisation for Research and Treatment of Cancer in Brussels.
Many thanks to the Austrian Society for Hematology and Medical Oncology (OeGHO) and all colleagues whose support made this work possible.
Looking forward to new and engaging projects that continue to drive innovation in oncology trials and treatment strategies.”
Recently EORTC – European Organisation for Research and Treatment of Cancer shared Hannah Christina Puhr’s post on LinkedIn:
“We are proud to see that the time our fellows spend at EORTC HQ helps advance their careers and enables them to make valuable contributions to the scientific community, as exemplified by former fellow Hannah Puhr. Well done on your achievement!
For more info about our Fellowships.”
Quoting Austrian Society for Hematology and Medical Oncology (OeGHO)’s original post:
“Forschung promote. Innovation.
We at OeGHO are particularly proud to be able to award the Innovation Award again in 2025 – our research funding award for outstanding scientific work that makes a significant contribution to the quality care Versorgung of oncological patients.
This year’s award winners:
1st place – € 3,000
Gabriel RINNERTHALER, Medical University of Graz
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
2nd place – € 2,000
Isabel HEIDEGGER-PIRCHER, Medical University of Innsbruck – Urology
Prediction of clinically significant prostate cancer by a specific collagen-related transcriptome, proteome and urinome signature
3rd place – €1,000 each
Katharina STEGER, Medical University of Innsbruck – Gynaecology
Differences in immunogenicity of TP53-mutated cancers with low tumor mutational burden (TMB)
and
Hannah Christina Puhr, Medical University of Vienna
Kidney function assessment for eligibility in clinical cancer trials – EORTC data
The works will be presented as part of the Best of ASCO and Best of Hematology 2025. Short videos on the research projects are now available for our members in the members’ area on oegho.at.
A big thank you to Roche Austria, who made this award possible through their support.
To register for Best of ASCO and Best of Hematology 2025.
”
More posts featuring Innovation Award.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023